Insider · CIK 0001635046

Vickers Philip J.

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001635046

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-01	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+214K sh	—	—	214,400
2023-06-06	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,643
2022-06-08	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,478
2022-06-08	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,478
2022-05-04	Revance Therapeutics, Inc.A Award	Director	AAward	+6,059 sh	—	—	29,722
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,343
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,756
2021-07-07	TECXTectonic Therapeutic, Inc.P Purchase	Director	PPurchase	+4,800 sh	$8.35	+$40.1K	4,800
2021-06-10	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.4K sh	—	—	17,438
2021-05-05	Revance Therapeutics, Inc.A Award	Director	AAward	+4,013 sh	—	—	23,663
2021-05-05	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+7,551 sh	—	—	7,551
2020-06-04	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2020-05-14	Revance Therapeutics, Inc.A Award	Director	AAward	+6,000 sh	—	—	19,650
2020-05-14	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-06-11	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,675 sh	—	—	9,675
2019-05-09	Revance Therapeutics, Inc.A Award	Director	AAward	+4,500 sh	—	—	13,650
2019-05-09	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2019-01-07	TECXTectonic Therapeutic, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.7K sh	—	—	18,743
2018-05-10	Revance Therapeutics, Inc.A Award	Director	AAward	+3,000 sh	—	—	9,150
2018-05-10	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2018-03-16	Revance Therapeutics, Inc.P Purchase	Director	PPurchase	+2,250 sh	$31.25	+$70.3K	5,250
2018-03-16	Revance Therapeutics, Inc.P Purchase	Director	PPurchase	+900 sh	$31.20	+$28.1K	6,150
2017-05-11	Revance Therapeutics, Inc.A Award	Director	AAward	+3,000 sh	—	—	3,000
2017-05-11	Revance Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2016-05-05	Revance Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2015-05-07	Revance Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2015-02-26	Revance Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000

Recent filings

Accepted (ET)
Apr 34
Vickers Philip J.0001635046-26-000005
SEC(opens sec.gov)
Jun 84
Vickers Philip J.0001127602-23-018287
SEC(opens sec.gov)
Jun 104
Vickers Philip J.0001127602-22-017244
SEC(opens sec.gov)
May 134/A
Vickers Philip J.0001479290-22-000068
SEC(opens sec.gov)
May 64
Vickers Philip J.0001479290-22-000064
SEC(opens sec.gov)
Jul 84
Vickers Philip J.0001127602-21-021729
SEC(opens sec.gov)
Jun 144
Vickers Philip J.0001127602-21-019828
SEC(opens sec.gov)
May 74
Vickers Philip J.0001479290-21-000116
SEC(opens sec.gov)
Jun 54
Vickers Philip J.0001127602-20-019015
SEC(opens sec.gov)
May 154
Vickers Philip J.0001479290-20-000069
SEC(opens sec.gov)
Jun 134
Vickers Philip J.0000899243-19-016860
SEC(opens sec.gov)
May 104
Vickers Philip J.0001479290-19-000062
SEC(opens sec.gov)
Jan 94
Vickers Philip J.0000899243-19-000842
SEC(opens sec.gov)
May 114
Vickers Philip J.0001479290-18-000081
SEC(opens sec.gov)

Companies

Address

C/O AKEBIA THERAPEUTICS, INC 245 FIRST STREET

CAMBRIDGE, MA, 02142